Wilson Sonsini advised Zymeworks on the deal. Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Ltd. announced that they entered into an exclusive license agreement to develop...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion...
You must be a Standard 1 Year member to access this content.
Sheppard Mullin and Winston & Strawn served as counsel to Alkuri Global Acquisition Corp. on the deal. Freshfields advised Dr. Ali Parsa, Founder, CEO and major...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Pinsent Masons advised 4D pharma plc on the deal. 4D pharma plc, a Leeds, UK-based pharmaceutical company leading the development...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised Prometheus Biosciences on the deal, while Davis Polk advised the representatives of the underwriters. Prometheus Biosciences,...
You must be a Standard 1 Year member to access this content.
